75
Participants
Start Date
July 1, 2025
Primary Completion Date
June 1, 2029
Study Completion Date
June 1, 2030
Medication for opioid use disorder
A medication treatment component delivered in Week 1 as part of a 2×2 factorial SMART design. The exact content (e.g., treatment modality or intensity) will be finalized based on model results from Aim 1, which identifies optimal dynamic treatment regimes.
psychotherapy
A behavioral treatment component delivered in Week 1 as part of a 2×2 factorial SMART design. The exact content (e.g., treatment modality or intensity) will be finalized based on model results from Aim 1, which identifies optimal dynamic treatment regimes.
Discovery Behavioral Health, Irvine
National Institute on Drug Abuse (NIDA)
NIH
Brigham and Women's Hospital
OTHER